These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 24673436)

  • 1. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):147-51. PubMed ID: 23016266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
    Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
    Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
    Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ
    Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ niches and single cells in glioblastoma have different phenotypes.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2011 Aug; 104(1):129-43. PubMed ID: 21184132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells.
    Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X
    Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
    Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
    Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.